J&J to cut 400 jobs, 150 in NJ

April 30, 2008 8:23:27 AM PDT
Health care giant Johnson & Johnson says its eliminating about 400 sales jobs in the United States, including about 150 in New Jersey, by year's end. Drug safety problems are being blamed.

The New Brunswick, N.J.-based company is consolidating marketing and sales departments at its biotechnology businesses.

The company notified employees Tuesday. The company says the layoffs are in response to falling sales of Procrit - a type of anemia drug that stimulates formation of red blood cells.

Procrit sales have plunged since federal regulators put new safety warnings on such drugs last year.